GLMD — GALMED PHARMACEUTICALS LTD
As of Q2 2026, 4 SEC-registered investment managers reported holding GLMD (GALMED PHARMACEUTICALS LTD) in their latest 13F filings, with a combined reported value of $48.37K across 86.95K shares. That is -7.8% by share count (-7.35K shares) versus the previous quarter, while reported value moved +4.9%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Citadel Advisors history | Q2 2026 | 86.85K | $48.31K | 0.00% | Add |
| Two Sigma Investments history | Q1 2026 | 80.18K | $39.29K | 0.00% | Reduce |
| Renaissance Technologies history | Q3 2022 | 50.79K | $16.00K | 0.00% | Add |
| Millennium Management history | Q3 2023 | 20.13K | $12.48K | 0.00% | Add |
| Geode Capital Management history | Q1 2023 | 27.18K | $11.59K | 0.00% | Hold |
| Citigroup Inc history | Q2 2022 | 3.70K | $3.00K | 0.00% | Add |
| JPMorgan Chase & Co history | Q1 2022 | 745 | $1.00K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 56 | $31 | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 43 | $24 | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 3 | $2 | 0.00% | Reduce |
| Bank of America Corp history | Q2 2024 | 1 | $0 | — | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Two Sigma Investments sold 80.18K sh · $39.29K
Fund Position History — shares by quarter (top 11 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 28.11K | — | 12.59K | 59.62K | 18.63K | — | 40.84K | — | 40.50K | 11.25K | — | — | — | — | — | — | 50.49K | 38.18K | 11.38K | 86.85K |
| Morgan Stanley | 164.50K | 160.80K | 165.30K | 195.70K | 189.62K | 180.72K | 204.25K | 12.50K | 20.03K | 82.47K | 14.50K | 36.21K | 104 | 12.53K | 7.38K | 33.57K | 98 | 298 | 157 | 56 |
| Wells Fargo & Co | 6.33K | 6.33K | 6.33K | 6.33K | 4.05K | 3.05K | 3.05K | 204 | 204 | 204 | 204 | 204 | 18 | 18 | 9 | 9 | 9 | 9 | 43 | 43 |
| UBS Group AG | 160 | 6.36K | — | 6.06K | 26.99K | 21.43K | 4.31K | 1 | 28 | — | 2.26K | 280 | 5.27K | 6.72K | 1.10K | 6.90K | 963 | 1.81K | 2.55K | 3 |
| Two Sigma Investments | — | — | — | — | — | — | — | — | 30.72K | 23.52K | — | — | — | — | — | — | 21.20K | 112.15K | 80.18K | — |
| JPMorgan Chase & Co | — | — | 745 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | 31.60K | 50.79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1 | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | — | 650 | 3.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 27.18K | 27.18K | 27.18K | 27.18K | 27.18K | 27.18K | 27.18K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | 13.04K | 53.24K | 10.74K | 50.75K | 46.87K | 149.22K | 131.63K | 14.91K | 20.13K | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details